Vimarsana
Biggest News Aggregation in the World

Microbial Expression Systems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Microbial Expression Systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Microbial Expression Systems Today - Breaking & Trending Today

Ambrosia Bio Leverages Ginkgo Enzyme Services to Develop a More Scalable Enzymatic Process for Allulose - Vimarsana News

Ambrosia Bio Leverages Ginkgo Enzyme Services to Develop a More Scalable Enzymatic Process for Allulose

/PRNewswire/ -- Ambrosia Bio, an Israeli foodtech company developing novel bioprocesses for the global sugar replacement industry, and Ginkgo Bioworks (NYSE:...

Voodoo Scientific Leverages Ginkgo Enzyme Services to Develop Enzymatic Processing Aid to Eliminate the Harsh "Bite" from Distilled Alcoholic Beverages - Vimarsana News

Voodoo Scientific Leverages Ginkgo Enzyme Services to Develop Enzymatic Processing Aid to Eliminate the Harsh "Bite" from Distilled Alcoholic Beverages

LOS ANGELES and BOSTON, June 28, 2023 /PRNewswire/ -- Voodoo Scientific, a company creating capabilities to help distillers deliver meaningful innovation, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming ...

Lonza and Doer Biologics in expression system license deal - Vimarsana News

Lonza and Doer Biologics in expression system license deal

Lonza has signed a licensing agreement with clinical-stage biopharma, Zhejiang Doer Biologics, whereby the Hangzhou, China based biopharma company will develop multi-specific biotherapeutics using the Swiss CDMO’s XS Pichia.

Increased demand for CDMO microbial outsourcing services - Vimarsana News

Increased demand for CDMO microbial outsourcing services

Biotech innovators are looking to CDMOs for their key microbial expertise in order to move their therapies from lab to the market, says Lonza.

Biotech Ingredients Market to Garner $75.3 Billion, Globally, By 2028 at 4.8% CAGR, Says Allied Market Research - Vimarsana News

Biotech Ingredients Market to Garner $75.3 Billion, Globally, By 2028 at 4.8% CAGR, Says Allied Market Research

Share this article PORTLAND, Ore., July 5, 2021 /PRNewswire/ -- Allied Market Research published a report, titled,  "Biotech Ingredients Market by Type (Active Pharmaceutical Ingredients and Biosimilars), Product (Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, and Blood Factors), and Expression Systems (Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, and Insect Expression Systems): Global Opportunity Analysis and Industry Forecast, 2021–2028." According to the rep...